Jones Financial Companies’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4M | Buy |
31,922
+7,870
| +33% | +$839K | ﹤0.01% | 603 |
|
|
2025
Q1 | $2.39M | Buy |
24,052
+8,676
| +56% | +$863K | ﹤0.01% | 612 |
|
|
2024
Q4 | $1.37M | Buy |
15,376
+6,118
| +66% | +$546K | ﹤0.01% | 660 |
|
|
2024
Q3 | $773K | Buy |
9,258
+5,946
| +180% | +$496K | ﹤0.01% | 680 |
|
|
2024
Q2 | $255K | Buy |
3,312
+2,510
| +313% | +$193K | ﹤0.01% | 758 |
|
|
2024
Q1 | $54.9K | Buy |
802
+245
| +44% | +$16.8K | ﹤0.01% | 715 |
|
|
2023
Q4 | $32.2K | Buy |
557
+193
| +53% | +$11.2K | ﹤0.01% | 533 |
|
|
2023
Q3 | $19.2K | Buy |
364
+183
| +101% | +$9.66K | ﹤0.01% | 437 |
|
|
2023
Q2 | $9.79K | Buy |
181
+121
| +202% | +$6.55K | ﹤0.01% | 468 |
|
|
2023
Q1 | $3K | Sell |
60
-87
| -59% | -$4.35K | ﹤0.01% | 544 |
|
|
2022
Q4 | $7K | Buy |
147
+87
| +145% | +$4.14K | ﹤0.01% | 501 |
|
|
2022
Q3 | $2K | Sell |
60
-99
| -62% | -$3.3K | ﹤0.01% | 506 |
|
|
2022
Q2 | $6K | Sell |
159
-239
| -60% | -$9.02K | ﹤0.01% | 523 |
|
|
2022
Q1 | $18K | Sell |
398
-164
| -29% | -$7.42K | ﹤0.01% | 447 |
|
|
2021
Q4 | $24K | Buy |
562
+300
| +115% | +$12.8K | ﹤0.01% | 437 |
|
|
2021
Q3 | $11K | Hold |
262
| – | – | ﹤0.01% | 485 |
|
|
2021
Q2 | $11K | Buy |
262
+181
| +223% | +$7.6K | ﹤0.01% | 456 |
|
|
2021
Q1 | $3K | Sell |
81
-179
| -69% | -$6.63K | ﹤0.01% | 698 |
|
|
2020
Q4 | $9K | Buy |
+260
| New | +$9K | ﹤0.01% | 441 |
|
|
2013
Q4 | – | Sell |
-186
| Closed | -$2K | – | 263 |
|
|
2013
Q3 | $2K | Hold |
186
| – | – | ﹤0.01% | 645 |
|
|
2013
Q2 | $2K | Buy |
+186
| New | +$2K | ﹤0.01% | 721 |
|